Corporate Compliance

DOJ, EUSA Pharma settle false claims action

Compliance Monitor, March 28, 2012

EUSA Pharma, a radiopharmceutical company based in Langhorne, Pa., has agreed to pay $180,000 to settle false claims allegations stemming from its suspected practice of encouraging providers to submit inflated claims to Medicare, according to a March 23 Department of Justice press release.

The Society of Nuclear Medicine informed the company that only one claim may be submitted for scans using ProstaScint, a EUSA Pharma product, according to court documents. However, EUSA Pharma still encouraged providers to submit multiple claims for images.

Read more on the U.S. Department of Justice website.

Most Popular